{"transactions":[{"id":1618586,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:00:45.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":168750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 22, 2025 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued services through such date."}],"balance_after":168750,"derivative":{"exercise_price":3.68,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":168750},"source":{"system":"sec-edgar","filing":"0001209191-24-003966","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919124003966/doc4.xml","form_type":"4"}},{"id":1618585,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2024-02-26T23:00:45.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (RSU) award. One-third (1/3) of the total number of RSUs shall vest on January 1, 2025 and one-third (1/3) of the remaining RSUs shall vest each year thereafter on anniversary of the vesting commencement date, subject to the Reporting Person's continuous service through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of Common Stock."}],"balance_after":28125,"source":{"system":"sec-edgar","filing":"0001209191-24-003966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919124003966/doc4.xml","form_type":"4"}},{"id":1989609,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-27T22:00:03.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2024 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":175000,"derivative":{"exercise_price":2.5,"expiration_date":"2033-02-22","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-013239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919123013239/doc4.xml","form_type":"4"}},{"id":2298183,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T21:30:42.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable on April 8, 2023 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous services through such vesting date."}],"balance_after":10000,"derivative":{"exercise_price":3.22,"expiration_date":"2032-04-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-024185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919122024185/doc4.xml","form_type":"4"}},{"id":2298182,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-12T21:30:42.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":25399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable October 8, 2022 and the remaining shares will vest in 18 equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":25399,"derivative":{"exercise_price":3.22,"expiration_date":"2032-04-07","underlying":"Common Stock","underlying_shares":25399},"source":{"system":"sec-edgar","filing":"0001209191-22-024185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919122024185/doc4.xml","form_type":"4"}},{"id":2411322,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-04T23:19:49.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 3, 2023 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":175000,"derivative":{"exercise_price":2.72,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-22-007310","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919122007310/doc4.xml","form_type":"4"}},{"id":2735485,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T21:32:45.000Z","date":"2020-11-25","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 5, 2020, the Reporting Person was granted the option to purchase shares of the Issuer's common stock, subject to a performance-based vesting condition to be satisfied upon the achievement of a particular milestone related to the Issuer's clinical trial, and further subject to the Reporting Person's continuous service through such vesting date. Such option vested in full on November 25, 2020 upon the satisfaction of such performance-based vesting condition."}],"balance_after":44000,"derivative":{"exercise_price":3.66,"exercise_date":"2020-11-25","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001209191-21-029048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919121029048/doc4.xml","form_type":"4"}},{"id":2935775,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-21T22:04:16.000Z","date":"2020-12-17","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":175000,"derivative":{"exercise_price":2.82,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-20-064674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919120064674/doc4.xml","form_type":"4"}},{"id":3007838,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-13T20:38:57.000Z","date":"2020-10-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the shares subject to the Stock Option will vest and become exercisable on October 11, 2021 and the remaining shares will vest in 12 equal installments thereafter, subject to the Reporting Person's continued service through each such date."}],"balance_after":20000,"derivative":{"exercise_price":5.65,"expiration_date":"2030-10-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-054642","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919120054642/doc4.xml","form_type":"4"}},{"id":3326597,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel, Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-03T00:47:30.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on January 1, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":75000,"derivative":{"exercise_price":4.15,"expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-20-000452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919120000452/doc4.xml","form_type":"4"}},{"id":3333518,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-20T21:18:04.000Z","date":"2019-12-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on December 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":100000,"derivative":{"exercise_price":4.42,"expiration_date":"2029-12-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-061538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919119061538/doc4.xml","form_type":"4"}},{"id":3560004,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":93876,"kind":"person","name":"Perone Thomas Michael","position":1,"cik":"0001771761","reported_name":"Perone Thomas Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-09T00:30:28.000Z","date":"2019-04-03","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on March 25, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date."}],"balance_after":125000,"derivative":{"exercise_price":1.92,"expiration_date":"2029-03-24","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-19-024055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919119024055/doc4.xml","form_type":"4"}}]}